PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Clinical Endocrinology10.1046/j.1365-2265.2001.01202.x200154111-13Dose and frequency titration of somatostatin analogues in the treatment of acromegaly - an injection of expediency?R. A. James, J. Gilroyhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2265.2001.01202.x, https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2265.2001.01202.x, http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2265.2001.01202.x/fullpdf
Medical Council10.21518/2079-701x-2017-3-75-792017375-79CURRENT VIEWS ON THE TREATMENT OF ACROMEGALY WITH SOMATOSTATIN ANALOGUESI. A. Ilovaiskayahttps://www.med-sovet.pro/jour/article/viewFile/1754/1698
Endocrine Connections10.1530/ec-16-0038201654167-173Attitudes and preferences in patients with acromegaly on long-term treatment with somatostatin analoguesCecilia Follin, Sven Karlssonhttps://ec.bioscientifica.com/view/journals/ec/5/4/167.xml
Sandostatin® in the Treatment of Acromegaly10.1007/978-3-642-73694-0_251988151-152Somatostatin Octapeptide (SMS 201–995, Sandostatin®) in the Medical Treatment of AcromegalyJ. A. H. Wass, K. Davidson, S. Medbak, G. M. Besserhttp://link.springer.com/content/pdf/10.1007/978-3-642-73694-0_25
Sandostatin® in the Treatment of Acromegaly10.1007/978-3-642-73694-0_9198875-79Medical Treatment of Acromegaly. Dopaminergic Agonists and Long-Acting SomatostatinA. Liuzzi, P. G. Chiodini, R. Cozzi, D. Dallabonzana, G. Oppizzi, M. M. Petroncinihttp://link.springer.com/content/pdf/10.1007/978-3-642-73694-0_9
Sandostatin® in the Treatment of Acromegaly10.1007/978-3-642-73694-0_10198881-82Treatment of Acromegaly with the Somatostatin Analogue SMS 201–995 (Sandostatin®)H.-J. Quabbe, U. Plöckingerhttp://link.springer.com/content/pdf/10.1007/978-3-642-73694-0_10
Clinical Endocrinology10.1111/cen.122072013n/a-n/aControl of growth hormone and IGF1 in patients with acromegaly in the UK: responses to medical treatment with somatostatin analogues and dopamine agonistsTrevor A. Howlett, Debbie Willis, Gillian Walker, John A.H. Wass, Peter J. Trainer, https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fcen.12207
Neuroendocrinology10.1159/0003777042015103150-58Medical Treatment of Acromegaly with Dopamine Agonists or Somatostatin AnalogsPhilippe Chansonhttps://www.karger.com/Article/Pdf/377704, https://www.karger.com/Article/Pdf/377704
Value in Health10.1016/s1098-3015(10)66682-x2008116A506-A507PDB34 MONITORING OF TREATMENT COSTS AFTER REIMBURSEMENT DECISION: SOMATOSTATIN ANALOGUES FOR ACROMEGALYJ Valentim, V Passos, A Calabróhttps://api.elsevier.com/content/article/PII:S109830151066682X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S109830151066682X?httpAccept=text/plain
Journal of Endocrinological Investigation10.1007/bf033457972012356613-615Pre-surgical treatment with somatostatin analogues in patients with acromegaly: The case forD. Ferone, F. Gatto, F. Minutohttp://link.springer.com/content/pdf/10.1007/BF03345797.pdf, http://link.springer.com/article/10.1007/BF03345797/fulltext.html, http://link.springer.com/content/pdf/10.1007/BF03345797